Health Innovation Company Completes Expansion In Kansas City, Missouri

Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has completed the second phase of its $5.5 million expansion in Kansas City, Missouri.  Catalent said its 450,000 sq. ft. facility provides a range of fully integrated support services, from development and analytical support through to packaging and distribution.

“Catalent customers have benefitted from our integrated analytical, oral solid manufacturing, and clinical supply services which our Kansas City campus has offered continuously for over 18 years,” commented Kevin Economos, General Manager of Clinical Supply Services at the site. “These latest expansions are critical enablers to our customers’ continued growth, that reinforce our comprehensive global network, and enhance Catalent’s role as a market leader in the clinical supply industry.”

The expansion includes additional controlled temperature storage capacity with 450 new pallet locations and 500 new high-density storage locations. A new sampling room has been installed, as well as a new emergency generator to ensure the security and integrity of samples in storage.

For more information on Missouri’s health innovation industry check out our webpage, or contact Steve Johnson, CEO of Missouri Partnership, at 314.725.2688 or via our contact form. He will answer any questions you might have, and explain how Missouri Partnership can help with your business expansion and investment needs.

What Next?